345 related articles for article (PubMed ID: 17559623)
1. Differential expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA in periodontal diseases.
Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Berdeli A; Atilla G; McKay IJ; Hughes FJ; Belibasakis GN
J Periodontal Res; 2007 Aug; 42(4):287-93. PubMed ID: 17559623
[TBL] [Abstract][Full Text] [Related]
2. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis.
Lu HK; Chen YL; Chang HC; Li CL; Kuo MY
J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732
[TBL] [Abstract][Full Text] [Related]
3. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio.
Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Atilla G; Hughes FJ; Belibasakis GN
J Clin Periodontol; 2007 May; 34(5):370-6. PubMed ID: 17355365
[TBL] [Abstract][Full Text] [Related]
4. Smoking modulates interleukin-6:interleukin-10 and RANKL:osteoprotegerin ratios in the periodontal tissues.
César-Neto JB; Duarte PM; de Oliveira MC; Tambeli CH; Sallum EA; Nociti FH
J Periodontal Res; 2007 Apr; 42(2):184-91. PubMed ID: 17305878
[TBL] [Abstract][Full Text] [Related]
5. RANKL upregulation associated with periodontitis and Porphyromonas gingivalis.
Wara-aswapati N; Surarit R; Chayasadom A; Boch JA; Pitiphat W
J Periodontol; 2007 Jun; 78(6):1062-9. PubMed ID: 17539720
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease.
Garlet GP; Martins W; Fonseca BA; Ferreira BR; Silva JS
J Clin Periodontol; 2004 Aug; 31(8):671-9. PubMed ID: 15257746
[TBL] [Abstract][Full Text] [Related]
7. High expression levels of receptor activator of nuclear factor-kappa B ligand associated with human chronic periodontitis are mainly secreted by CD4+ T lymphocytes.
Vernal R; Dutzan N; Hernández M; Chandía S; Puente J; León R; García L; Del Valle I; Silva A; Gamonal J
J Periodontol; 2006 Oct; 77(10):1772-80. PubMed ID: 17032122
[TBL] [Abstract][Full Text] [Related]
8. Human beta defensin-1 and -2 expression in the gingiva of patients with specific periodontal diseases.
Vardar-Sengul S; Demirci T; Sen BH; Erkizan V; Kurulgan E; Baylas H
J Periodontal Res; 2007 Oct; 42(5):429-37. PubMed ID: 17760820
[TBL] [Abstract][Full Text] [Related]
9. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.
Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mochizuki S; Ikeda T; Mukai M; Okada Y
J Pathol; 2009 Aug; 218(4):530-9. PubMed ID: 19455604
[TBL] [Abstract][Full Text] [Related]
10. [Osteoprotegerin mRNA/receptor activator of NF-kappaB ligand mRNA expressions in bone tissues of glucocorticoid-induced osteonecrosis of the femoral head].
Wang J; Wang K; Shi Z; Zhang M
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Oct; 22(10):1161-4. PubMed ID: 18979868
[TBL] [Abstract][Full Text] [Related]
11. Diabetes modulates gene expression in the gingival tissues of patients with chronic periodontitis.
Duarte PM; Neto JB; Casati MZ; Sallum EA; Nociti FH
Oral Dis; 2007 Nov; 13(6):594-9. PubMed ID: 17944678
[TBL] [Abstract][Full Text] [Related]
12. Imbalance of the osteoprotegerin/RANKL ratio in bone marrow microenvironment after allogeneic hemopoietic stem cell transplantation.
Ricci P; Tauchmanova L; Risitano AM; Carella C; Mazziotti G; Lombardi G; Colao A; Rotoli B; Selleri C
Transplantation; 2006 Dec; 82(11):1449-56. PubMed ID: 17164716
[TBL] [Abstract][Full Text] [Related]
13. [Osteoprotegerin and receptor activator of nuclear factor kappa B ligand mRNAs expression in BMSCs of glucocorticoid-induced necrosis of the femoral head patients].
Wang J; Gao H; Wang K; Li W; Shi Z; Zhang M
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Jul; 23(7):777-80. PubMed ID: 19662974
[TBL] [Abstract][Full Text] [Related]
14. Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kappa B ligand, interleukin (IL) -17, IL-10 and transforming growth factor-beta during the progression of chronic periodontitis.
Dutzan N; Gamonal J; Silva A; Sanz M; Vernal R
J Clin Periodontol; 2009 May; 36(5):396-403. PubMed ID: 19419438
[TBL] [Abstract][Full Text] [Related]
15. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors.
Garlet GP; Cardoso CR; Silva TA; Ferreira BR; Avila-Campos MJ; Cunha FQ; Silva JS
Oral Microbiol Immunol; 2006 Feb; 21(1):12-20. PubMed ID: 16390336
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of RANKL, RANK and OPG in gingival tissue of patients with periodontitis.
Giannopoulou C; Martinelli-Klay CP; Lombardi T
Acta Odontol Scand; 2012 Dec; 70(6):629-34. PubMed ID: 22214279
[TBL] [Abstract][Full Text] [Related]
17. Experimental periodontitis in mice selected for maximal or minimal inflammatory reactions: increased inflammatory immune responsiveness drives increased alveolar bone loss without enhancing the control of periodontal infection.
Trombone AP; Ferreira SB; Raimundo FM; de Moura KC; Avila-Campos MJ; Silva JS; Campanelli AP; De Franco M; Garlet GP
J Periodontal Res; 2009 Aug; 44(4):443-51. PubMed ID: 18973535
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of RANK/RANKL/OPG gene polymorphisms in aggressive periodontitis.
Soedarsono N; Rabello D; Kamei H; Fuma D; Ishihara Y; Suzuki M; Noguchi T; Sakaki Y; Yamaguchi A; Kojima T
J Periodontal Res; 2006 Oct; 41(5):397-404. PubMed ID: 16953816
[TBL] [Abstract][Full Text] [Related]
19. The potential role of interleukin-17 in the immunopathology of periodontal disease.
Takahashi K; Azuma T; Motohira H; Kinane DF; Kitetsu S
J Clin Periodontol; 2005 Apr; 32(4):369-74. PubMed ID: 15811054
[TBL] [Abstract][Full Text] [Related]
20. Roles of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease.
Nagasawa T; Kiji M; Yashiro R; Hormdee D; Lu H; Kunze M; Suda T; Koshy G; Kobayashi H; Oda S; Nitta H; Ishikawa I
Periodontol 2000; 2007; 43():65-84. PubMed ID: 17214836
[No Abstract] [Full Text] [Related]
[Next] [New Search]
